Parkkila, Seppo
University Hospital of Tampere,
Finland
2024 Rank: 64592
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 199 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64592 | 47306 |
| Total Cites | 10955 | 15692 |
| H-index | 53 | 65 |
| Hm-index | 22 | 26 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 56 | 73 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 1835 | 2383 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 3702 | 5227 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7017 | 8349 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.88 |
| Self-Citation Percentage |
30.19%
|
|
Parkkila, Seppo
Tampere University,
Finland
2023 Rank: 62864
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2599 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62864 | 45958 |
| Total Cites | 10399 | 14927 |
| H-index | 52 | 64 |
| Hm-index | 21 | 25 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 55 | 72 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 1789 | 2336 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 3472 | 4919 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6614 | 7883 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.89 |
| Self-Citation Percentage |
30.33%
|
|
Parkkila, Seppo
Tampere University,
Finland
2022 Rank: 61846
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2677 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61846 | 45331 |
| Total Cites | 9789 | 13989 |
| H-index | 50 | 61 |
| Hm-index | 20 | 24 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 50 | 66 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1715 | 2242 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 3241 | 4569 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6160 | 7339 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.91 |
| Self-Citation Percentage |
30.02%
|
|
Parkkila, Seppo
Tampereen Yliopisto,
Finland
2020 Rank: 58661
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2218 out of 135836 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58661 | 42821 |
| Total Cites | 8757 | 12595 |
| H-index | 47 | 57 |
| Hm-index | 19 | 23 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 44 | 59 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 1601 | 2101 |
| Number of Single+First+Last Authored Papers | 106 | 106 |
| Total Cites to Single+First+Last Authored Papers | 2888 | 4089 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5473 | 6570 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.92 |
| Self-Citation Percentage |
30.47%
|
|